Your trusted destination for CME, CPD & Medical Education across the Middle East.
Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
Dr. Michael J. Lenardo is a world-renowned physician-scientist, molecular immunologist, and pioneer in human genetics whose career has redefined fundamental concepts of immune system regulation, programmed cell death, and targeted precision therapy for inherited immune disorders.
He completed his undergraduate studies at Johns Hopkins University, graduating with a Bachelor of Arts in Natural Sciences in 1977. He earned his Doctor of Medicine (M.D.) degree from Washington University School of Medicine in St. Louis in 1981, where he was introduced to molecular virology and molecular biology. Following clinical residency training in internal medicine and research at the University of Iowa, Dr. Lenardo conducted groundbreaking postdoctoral research at the Whitehead Institute for Biomedical Research and the Massachusetts Institute of Technology (MIT) under Nobel Laureate David Baltimore and Louis Staudt, contributing fundamental early insights into transcription factors,including the purification and regulatory characterization of NF-κκB.
In 1989, Dr. Lenardo joined the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) as an independent principal investigator. He went on to serve as Chief of the Molecular Development of the Immune System Section and Co-Director of the NIAID Clinical Genomics Program. Over more than three decades at the NIH, his laboratory integrated basic molecular biology, functional cellular assays, and clinical genomics to discover the precise molecular and genetic causes of numerous primary immunodeficiency diseases and autoimmune syndromes.
Dr. Lenardo is widely recognized for discovering activation-induced cell death (AICD) and interleukin-2 (IL-2) induced apoptosis, mechanisms critical for immune self-tolerance and preventing autoimmunity. His translational discoveries have illuminated the molecular pathobiology of several inherited human diseases, including:
In addition to his laboratory breakthroughs, Dr. Lenardo's work on cellular homeostasis demonstrated how mTOR reactivation terminates autophagy and reforms functional lysosomes. He is also a passionate advocate for global scientific education, having co-founded several elite international graduate training partnerships, including the NIH Oxford-Cambridge Scholars Program, the NIH-Penn Immunology Graduate Partnership Program, and the NIH-Institut Pasteur Program.
Dr. Lenardo has received many of the highest honors awarded in biomedical science, including election to the National Academy of Sciences (2019), the National Academy of Medicine (2019), the American Academy of Arts and Sciences (2015), and appointment as an Officer of the Most Excellent Order of the British Empire (O.B.E.) by Queen Elizabeth II in 2006.

Sidra Medicine
Sidra Medicine